-
Continue reading →: The order revoking Pharmacyclics LLC’s patent covering IBRUTINIB, set aside by the IPAB
The hon’ble IPAB has allowed an appeal filed by the appellant, Pharmacyclics LLC, against the Order dated 04/03/2020 issued under Section 25(2) revoking Indian Patent no. IN 262968. The patent covers, amongst other compounds, a compound having an International Non-Proprietary Name (INN), IBRUTINIB, which is an active pharmaceutical ingredient (API) of…
-
Continue reading →: Pfizer granted a patent for Tofacitinib and its salts
The IPAB has recently allowed an appeal and granted a patent to Pfizer for its application 991/MUMNP/2003. This application claimed the compound 3-{(3R, 4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile and pharmaceutically acceptable salts thereof (Tofacitinib and its salts) and was refused by the patent office on various grounds, including anticipation by prior claiming and section…
-
Continue reading →: Filing of additional documents, data and evidence in support of the invention is allowed under the Patent Law
The IPAB has recently allowed an appeal and granted a patent to the University of Miami. The application claims were directed to pharmaceutical composition comprising coenzyme Q10 and the method of using co-enzyme Q10 for treatment of cancer. A composition of co-enzyme Q10 comprising a lipid has also been exemplified…
-
Continue reading →: Patent for Delgocitinib granted to Japan Tobacco
Dismissing the Pre-grant filed by Mr. Tapan Shah, the Indian Patent Office has granted a patent bearing Patent Application No. 640/CHENP/2012 entitled “Nitrogen containing spiro-ring compound and medicinal use of same” covering the commercial product, Delgocitinib. The claims of the application were directed to nitrogen containing spiro-ring compounds represented by…
-
Continue reading →: Importance of Opposition Board and Opposition Board recommendation reinstated by the IPAB
The Hon’ble IPAB, has maintained the stay granted on the order of the Controller revoking Indian Patent IN262968 covering the product Ibrutinib. Some facts of the case are provided below:- Patentee Pharmacyclics LLC was granted Indian Patent No.262968. The publication of the grant took place on 3rd October, 2014. On…
-
Continue reading →: Shri. B.P. Singh appointed as a technical member at the IPAB
A writ petition was filed by the Indian Drug Manufacturers Association before the Delhi High Court. The main grievance of the petitioner was that a technical member who is qualified in the patents Act has not been appointed to the IPAB. In the writ, it has been confirmed that vide…
-
Continue reading →: Invention cannot be denied patent protection only because it also employs a computer program
The Hon’ble IPAB has allowed the Indian patent application IN/PCT/2002/00705/DEL titled “METHOD AND DEVICE FOR ACCESSING INFORMATION SOURCES AND SERVIC ES OF THE WEB”, of ALLANI FERID by setting aside the impugned order of Indian Patent Office dated 7th February, 2020. The invention of appellant provided a forward looking solution…
-
Continue reading →: IPAB stays order of the controller revoking Novartis’s patent for Ceritinib
The Intellectual Property Appellate Board (IPAB) has stayed the order of the controller dated 16.08.2019 revoking Novartis’s patent covering the commercial product Ceritinib. Novartis had filed an appeal against the impugned order dated 16.08.2019 passed in the post grant opposition proceeding under Section 25(2) filed by Natco against Novartis’s patent…
-
Continue reading →: Nivolumab patent granted in India
The Indian Patent Office (IPO) has dismissed 4 pre-grant oppositions filed by Indian Pharmaceutical Alliance, Pankaj Kumar Singh, Restech Pharmaceuticals, and Dr. Reddy’s Laboratories Ltd. and has granted a patent to Indian Patent Application 5057/CHENP/2007 covering the commercial product Nivolumab. Nivolumab, sold under the brand name Opdivo, is a medication used…
-
Continue reading →: Order revoking Pharmacyclics patent for Ibrutinib stayed by the IPAB
Vide an order dated 12th June 2020, the Hon’ble Intellectual Property Appellate (IPAB) has stayed the order of the Deputy Controller revoking Indian Patent IN262968 covering the product Ibrutinib. The Hon’ble Board held that as per material available on record, the appellant has made a strong prima facie case in…
Greetings
Welcome to Patents Rewind, Anand and Anand’s Patents and Designs blog that offers you an Indian perspective on issues surrounding patent and design eligibility and enforcement through latest case law and developments in the Indian patents and designs landscape.
Let’s connect
Join us!
Stay updated with our posts.
Patents Rewind - An Anand and Anand Blog 